Three Retractions for Highly Cited Author

Robert Weinberg’s team at MIT is pulling three papers, noting some figure panels were composites of different experiments.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, MADCOVERBOYMIT cancer biologist Robert Weinberg and his colleagues have retracted two Genes & Development papers on the role of a microRNA in breast cancer metastases. The notices reference the retraction of a third, highly cited paper published in Cell. The Scientist has not yet heard from Weinberg nor the journal regarding this apparent withdrawal.

According to two identical notices in the March issue of Genes & Development, the alleged retraction in Cell came about “because original data were compiled from different replicate experiments in order to assemble certain figure panels. As the same analytical methodology was used in this [Genes & Development] manuscript, we believe that the responsible course of action is to retract the article.”

The retracted 2011 Genes & Development paper has been cited 78 times, while the 2009 paper in the same journal has been cited 96 times.

The 2009 Cell study has been cited 676 times. Cell’s press officer is looking into whether a retraction is in progress, and The Scientist will update this post once more information is available. Weinberg did not respond immediately ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies